Recursion Pharmaceuticals (RXRX) Return on Sales [ROS] (2020 - 2026)
Recursion Pharmaceuticals (RXRX) posted Return on Sales [ROS] of -1759.69% for Q2 2026, down 842.94 percentage points from -916.75% a year earlier but up 225.87 percentage points from the prior quarter.
Recursion Pharmaceuticals (RXRX) Return on Sales [ROS] (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Recursion Pharmaceuticals was -991.72%, up 14.09 percentage points year-over-year; for FY2025, it was -867.87%, down 53.77 percentage points from FY2024.
- Annual Return on Sales [ROS] has declined for three consecutive years, though with a five-year change of +1267.80 percentage points (FY2020 to FY2025).
- In prior years, Recursion Pharmaceuticals' Return on Sales [ROS] was -814.09% in FY2024 (-28.76 pp), -785.33% in FY2023 (-168.59 pp), -616.74% in FY2022 (+1179.05 pp) and -1795.79% in FY2021 (+339.88 pp).
- Quarterly Return on Sales [ROS] has run from a low of -4042.41% in Q4 2024 to a high of -304.84% in Q4 2025 over five years.
- On a year-over-year basis, Return on Sales [ROS] increased in two of the last eight quarters, with an average year-over-year change of -516.04 percentage points.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q4 2025, with a gain of 3737.57 percentage points; the weakest was Q4 2024, with a drop of 3134.05 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -1985.55% (Q1 2026), -304.84% (Q4 2025) and -3327.57% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 28.37% |
| 10 | Recursion Pharmaceuticals | 2.17 Bn | -429.42 Mn | -3.82 Mn | -1,759.69% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,759.69% |
| Mar 31, 2026 | -1,985.55% |
| Dec 31, 2025 | -304.84% |
| Sep 30, 2025 | -3,327.57% |
| Jun 30, 2025 | -916.75% |
| Mar 31, 2025 | -1,297.85% |
| Dec 31, 2024 | -4,042.41% |
| Sep 30, 2024 | -377.10% |
| Jun 30, 2024 | -697.39% |
| Mar 31, 2024 | -698.42% |
| Dec 31, 2023 | -908.36% |
| Sep 30, 2023 | -945.12% |
| Jun 30, 2023 | -741.72% |
| Mar 31, 2023 | -575.78% |
| Dec 31, 2022 | -445.91% |
| Sep 30, 2022 | -475.48% |
| Jun 30, 2022 | -862.54% |
| Mar 31, 2022 | -1,049.71% |
| Dec 31, 2021 | -2,564.55% |
| Sep 30, 2021 | -1,831.18% |
Recursion Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();